Company intelligence / Profile preview

Neurostream Technologies

Saint-Augustin-De-Desmaures, Quebec, Canadabloomberg.com ↗

Ownership: Private
Development stage: Preclinical

Overview

As of its acquisition by Otto Bock Healthcare in June 2011, Neurostream Technologies had developed proprietary neurostimulation devices targeting conditions such as sleep apnea and epilepsy. Its lead product was the "Neurostep System," which had not yet achieved European certification at the time of sale. No published clinical trial results are available from public sources; development appeared to be ongoing with some performance testing data referenced prior to acquisition.

Therapeutic areas: PulmonologyNeurology
Modalities: DeviceNeurostimulation device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Neurostep

Pre-clinical

Indications: Neural disorders, Muscular disorders

Partnerships

Victhom Human Bionics

Beyond the preview

Go deeper on Neurostream Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurostream Technologies.

Explore the full profile